KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in IntangiblesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Astrazeneca (AZN) over the last 15 years, with Q4 2025 value amounting to $4.0 million.

  • Astrazeneca's Exchange Rate Effect rose 10655.74% to $4.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $46.0 million, marking a year-over-year increase of 14946.24%. This contributed to the annual value of $46.0 million for FY2025, which is 14946.24% up from last year.
  • Per Astrazeneca's latest filing, its Exchange Rate Effect stood at $4.0 million for Q4 2025, which was up 10655.74% from -$12.0 million recorded in Q3 2025.
  • In the past 5 years, Astrazeneca's Exchange Rate Effect ranged from a high of $29.0 million in Q2 2025 and a low of -$67.0 million during Q1 2021
  • In the last 5 years, Astrazeneca's Exchange Rate Effect had a median value of -$10.0 million in 2022 and averaged -$11.9 million.
  • Per our database at Business Quant, Astrazeneca's Exchange Rate Effect plummeted by 31818.18% in 2024 and then skyrocketed by 58333.33% in 2025.
  • Quarter analysis of 5 years shows Astrazeneca's Exchange Rate Effect stood at $11.0 million in 2021, then crashed by 336.36% to -$26.0 million in 2022, then crashed by 38.46% to -$36.0 million in 2023, then crashed by 69.44% to -$61.0 million in 2024, then soared by 106.56% to $4.0 million in 2025.
  • Its Exchange Rate Effect stands at $4.0 million for Q4 2025, versus -$12.0 million for Q3 2025 and $29.0 million for Q2 2025.